Beam Therapeutics Inc (BEAM) — Cash Flow Reinvestment Rate
Beam Therapeutics Inc (BEAM) has a Cash Flow Reinvestment Rate of 0.75x as of December 2023, reinvesting $101.69 Million (capex $3.59 Million plus investments $98.10 Million) from operating cash flow of $135.07 Million. Explore Beam Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beam Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Beam Therapeutics Inc across 1 annual periods. Also explore how large is Beam Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Beam Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Beam Therapeutics Inc. For live market cap and broader valuation context, see BEAM company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 22.65x | $510.29 Million | $22.53 Million | $48.95 Million | — |